Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
337.97
-2.84 (-0.83%)
At close: Nov 13, 2026, 4:00 PM EST
339.00
+1.03 (0.30%)
After-hours: Nov 13, 2026, 7:42 PM EST
CRL Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, CRL stock has a consensus rating of "Buy" and an average price target of $350.57. The average 1-year stock price forecast is 3.73% higher than the current stock price, while the lowest is $145 (-57.10%) and the highest is $400 (+18.35%).
Price Target: $350.57 (+3.73%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CRL stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 9 | 9 | 11 | 11 | 11 |
| Buy | 4 | 3 | 4 | 4 | 3 | 3 |
| Hold | 2 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 17 | 16 | 16 | 18 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $325 → $388 | Buy | Maintains | $325 → $388 | +14.80% | Nov 11, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $345 → $385 | Buy | Maintains | $345 → $385 | +13.92% | Nov 6, 2026 |
| Mizuho Securities | Mizuho Securities | Hold Maintains $295 → $315 | Hold | Maintains | $295 → $315 | -6.80% | Nov 6, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 5, 2026 |
| UBS | UBS | Buy Reiterates $357 → $387 | Buy | Reiterates | $357 → $387 | +14.51% | Nov 5, 2026 |
Financial Forecast
Revenue This Year
3.95B
from 4.02B
Decreased by -1.56%
Revenue Next Year
4.07B
from 3.95B
Increased by 2.95%
EPS This Year
11.47
from 10.28
Increased by 11.60%
EPS Next Year
12.97
from 11.47
Increased by 13.04%
EPS and Forward PE are based on non-GAAP adjusted numbers.